Supplements
Effectiveness rated 45 due to promising but limited small-scale Russian trials (n=60-62) showing anxiolytic efficacy akin to benzos without cognitive impairment, e.g., Hamilton scale improvements and enkephalin modulation (PMID: 18454096, 25176261). However, no Western RCTs, small samples, unpublished doses, and no data on N-Acetyl variant drag it down. Safety at 85 reflects excellent short-term tolerability, minimal sides (nasal only), and immunomodulatory benefits (PMID: 18577961), tempered by
N-Acetyl Selank Amidate shows promise for anxiety relief based on limited Selank trials, with good safety. However, scant evidence, no FDA approval, and quality concerns make it suitable only for informed experimental use under medical supervision. Consider alternatives like approved anxiolytics.